MENU
EGRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Eagle Pharmaceuticals (EGRX) Ownership - Who owns Eagle Pharmaceuticals?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
50 Tice Boulevard
Phone
+1 201 326-5300
Employees
134
Web
http://www.eagleus.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
62.07M
P/E Ratio
5.64
Total Cash
15.35M
Projected Growth
N/A
Total Debt
71.62M
Revenue
257.55M
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
1.18
Total Debt/Equity
N/A
Revenue/Share
19.56 USD as % of share price
Fundamentals
EGRX
Capitalization
62.1M
P/E Ratio
5.64
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
15.4M
Total Cash/Share
1.18
Total Debt
71.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
19.56%
Revenue
258M
ROE
N/A
Book Value
252M
P/B Ratio
0.25
Cash Flow
N/A
Earnings
0.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
18K
Current Ratio
2.16
Current Revenue Per Employee
482432.84
Dividends Per Share - Security
N/A
EBITDA
55.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
73.92
Revenue To Assets
3.04
Shares Held By Institutions
97M
Shares Outstanding - Current
13M
Total Liabilities
153M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-10.899
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical preparations
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
50 Tice Boulevard
Phone
+1 201 326-5300
Employees
134
Web
http://www.eagleus.com